Shanghai Yizhong Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Shanghai Yizhong Pharmaceutical Co Ltd cash flow-to-debt ratio. Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Cash Flow-to-Debt Ratio of 0.25x as of September 2025, meaning its operating cash flow of CN¥21.03 Million could theoretically repay 0% of its total liabilities (CN¥82.76 Million) in one year. Check Shanghai Yizhong Pharmaceutical Co Ltd (688091) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shanghai Yizhong Pharmaceutical Co Ltd (2017–2024)
Cash flow-to-debt ratio of Shanghai Yizhong Pharmaceutical Co Ltd from 2017 to 2024. Historical debt coverage capacity for Shanghai Yizhong Pharmaceutical Co Ltd across 8 annual periods. Check 688091 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Shanghai Yizhong Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2017–2024)
Shanghai Yizhong Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2017 to 2024. Year-by-year debt coverage analysis for Shanghai Yizhong Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Shanghai Yizhong Pharmaceutical Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.92x | CN¥39.44 Million | CN¥42.97 Million | ▲ +15.1% |
| 2023 | 0.80x | CN¥86.55 Million | CN¥108.52 Million | ▼ -74.5% |
| 2022 | 3.13x | CN¥110.78 Million | CN¥35.42 Million | ▲ +260.4% |
| 2021 | -1.95x | CN¥-48.78 Million | CN¥25.02 Million | ▼ -47.6% |
| 2020 | -1.32x | CN¥-20.21 Million | CN¥15.30 Million | ▲ +32.3% |
| 2019 | -1.95x | CN¥-23.91 Million | CN¥12.26 Million | ▼ -212.9% |
| 2018 | -0.62x | CN¥-10.68 Million | CN¥17.15 Million | ▲ +12.5% |
| 2017 | -0.71x | CN¥-11.51 Million | CN¥16.17 Million | — |